RhumbLine Advisers’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.04M Sell
114,533
-14,662
-11% -$389K ﹤0.01% 1663
2025
Q1
$3.12M Sell
129,195
-1,032
-0.8% -$24.9K ﹤0.01% 1602
2024
Q4
$5.24M Sell
130,227
-218
-0.2% -$8.77K ﹤0.01% 1397
2024
Q3
$8.26M Buy
130,445
+3,187
+3% +$202K 0.01% 1160
2024
Q2
$6.75M Sell
127,258
-16,845
-12% -$893K 0.01% 1230
2024
Q1
$11.8M Buy
144,103
+14,911
+12% +$1.22M 0.01% 967
2023
Q4
$2.4M Sell
129,192
-1,696
-1% -$31.6K ﹤0.01% 1819
2023
Q3
$1.45M Buy
130,888
+3,059
+2% +$33.9K ﹤0.01% 2017
2023
Q2
$2.07M Buy
+127,829
New +$2.07M ﹤0.01% 1888
2022
Q2
Sell
-92,483
Closed -$277K 3243
2022
Q1
$277K Sell
92,483
-16,399
-15% -$49.1K ﹤0.01% 2666
2021
Q4
$501K Sell
108,882
-646
-0.6% -$2.97K ﹤0.01% 2509
2021
Q3
$688K Buy
109,528
+3,378
+3% +$21.2K ﹤0.01% 2406
2021
Q2
$636K Sell
106,150
-8,601
-7% -$51.5K ﹤0.01% 2444
2021
Q1
$726K Sell
114,751
-5,510
-5% -$34.9K ﹤0.01% 2324
2020
Q4
$677K Buy
120,261
+13,578
+13% +$76.4K ﹤0.01% 2314
2020
Q3
$621K Sell
106,683
-14,089
-12% -$82K ﹤0.01% 2187
2020
Q2
$871K Buy
120,772
+11,414
+10% +$82.3K ﹤0.01% 2099
2020
Q1
$512K Buy
109,358
+8,750
+9% +$41K ﹤0.01% 2153
2019
Q4
$807K Buy
100,608
+986
+1% +$7.91K ﹤0.01% 2175
2019
Q3
$685K Buy
99,622
+7,803
+8% +$53.7K ﹤0.01% 2209
2019
Q2
$762K Buy
91,819
+14,062
+18% +$117K ﹤0.01% 2176
2019
Q1
$773K Buy
77,757
+5,017
+7% +$49.9K ﹤0.01% 2147
2018
Q4
$556K Buy
72,740
+27,799
+62% +$212K ﹤0.01% 2245
2018
Q3
$783K Buy
44,941
+3,304
+8% +$57.6K ﹤0.01% 2105
2018
Q2
$395K Buy
+41,637
New +$395K ﹤0.01% 2410